1. Pharmacologic closure of patent ductus arteriosus in the premature infant;Friedman, W.F.; Herschklan, M.I.; Printz, M.P.; Pritlick, P.T.; Kirkpatrick, S.E.;N Engl J Med,1976
2. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus-a double blind controlled study;Yeh, T.F.; Luken, J.A.; Thalji, A.; Raval, D.; Carr, I.; Pildes, R.S.;J Pediatr,1981
3. Patent ductus arteriosus: recent advances in diagnosis and management;Bhat, R.; Fisher, E.; Raju, T.N.; Vidyasagar, D.;Pediatr Clin North Am,1982
4. Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus-clinical and echocardiographic assessment of response;Alpert, B.S.; Lewins, M.J.; Rowland, D.W.;J Pediatr,1979
5. Indomethacin treatment for symptomatic patent ductus arteriosus. A double blind controlled study;Pediatrics,1981